Literature DB >> 23609175

Antiplatelet therapy. Cangrelor succeeds, at last, in PCI.

Robert F Storey1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23609175     DOI： 10.1038/nrcardio.2013.61

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

Review 1.  Development and clinical use of prasugrel and ticagrelor.

Authors:  Shiraz Ahmad; Robert F Storey
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect.

Authors:  Steven R Steinhubl; Jennifer J Oh; Julie H Oestreich; Suellen Ferraris; Richard Charnigo; Wendell S Akers
Journal:  Thromb Res       Date:  2007-07-13       Impact factor: 3.944

3.  Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Authors:  Deepak L Bhatt; Gregg W Stone; Kenneth W Mahaffey; C Michael Gibson; P Gabriel Steg; Christian W Hamm; Matthew J Price; Sergio Leonardi; Dianne Gallup; Ezio Bramucci; Peter W Radke; Petr Widimský; Frantisek Tousek; Jeffrey Tauth; Douglas Spriggs; Brent T McLaurin; Dominick J Angiolillo; Philippe Généreux; Tiepu Liu; Jayne Prats; Meredith Todd; Simona Skerjanec; Harvey D White; Robert A Harrington
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

Review 4.  A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.

Authors:  R G Humphries; M J Robertson; P Leff
Journal:  Trends Pharmacol Sci       Date:  1995-06       Impact factor: 14.819

5.  Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.

Authors:  Dimitrios Alexopoulos; Ioanna Xanthopoulou; Vassilios Gkizas; George Kassimis; Konstantinos C Theodoropoulos; George Makris; Nikolaos Koutsogiannis; Anastasia Damelou; Grigorios Tsigkas; Periklis Davlouros; George Hahalis
Journal:  Circ Cardiovasc Interv       Date:  2012-11-20       Impact factor: 6.546

6.  Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

Authors:  Laurent Bonello; Udaya S Tantry; Rossella Marcucci; Ruediger Blindt; Dominick J Angiolillo; Richard Becker; Deepak L Bhatt; Marco Cattaneo; Jean Philippe Collet; Thomas Cuisset; Christian Gachet; Gilles Montalescot; Lisa K Jennings; Dean Kereiakes; Dirk Sibbing; Dietmar Trenk; Jochem W Van Werkum; Franck Paganelli; Matthew J Price; Ron Waksman; Paul A Gurbel
Journal:  J Am Coll Cardiol       Date:  2010-09-14       Impact factor: 24.094

7.  Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.

Authors:  Dominick J Angiolillo; Michael S Firstenberg; Matthew J Price; Pradyumna E Tummala; Martin Hutyra; Ian J Welsby; Michele D Voeltz; Harish Chandna; Chandrashekhar Ramaiah; Miroslav Brtko; Louis Cannon; Cornelius Dyke; Tiepu Liu; Gilles Montalescot; Steven V Manoukian; Jayne Prats; Eric J Topol
Journal:  JAMA       Date:  2012-01-18       Impact factor: 56.272

Review 8.  Biology and pharmacology of the platelet P2Y12 receptor.

Authors:  Robert F Storey
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  Intravenous platelet blockade with cangrelor during PCI.

Authors:  Deepak L Bhatt; A Michael Lincoff; C Michael Gibson; Gregg W Stone; Steven McNulty; Gilles Montalescot; Neal S Kleiman; Shaun G Goodman; Harvey D White; Kenneth W Mahaffey; Charles V Pollack; Steven V Manoukian; Petr Widimsky; Derek P Chew; Fernando Cura; Ivan Manukov; Frantisek Tousek; M Zubair Jafar; Jaspal Arneja; Simona Skerjanec; Robert A Harrington
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

10.  Platelet inhibition with cangrelor in patients undergoing PCI.

Authors:  Robert A Harrington; Gregg W Stone; Steven McNulty; Harvey D White; A Michael Lincoff; C Michael Gibson; Charles V Pollack; Gilles Montalescot; Kenneth W Mahaffey; Neal S Kleiman; Shaun G Goodman; Maged Amine; Dominick J Angiolillo; Richard C Becker; Derek P Chew; William J French; Franz Leisch; Keyur H Parikh; Simona Skerjanec; Deepak L Bhatt
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.